Skip to content
ppharmaranks
Menu
Class IIOngoing

Exenatide Injection recall

FDA recall D-0868-2026 · initiated Aug 28, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Sep 30, 2026How we research

Amneal Pharmaceuticals of New York, LLC recalled Exenatide Injection in Aug 2026 — an FDA Class II recall (D-0868-2026) because Defective Delivery System: Possibility of no medication in the prefilled pen.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Defective Delivery System: Possibility of no medication in the prefilled pen.

Another quality failure

A quality failure that does not fit the categories above.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: AP250095A, Exp 2/28/2027

Quantity recalled: 5,694 pens

Details

Product
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
Recalling company
Amneal Pharmaceuticals of New York, LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
USA Nationwide
Initiated
Aug 28, 2026
FDA report date
Sep 30, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Exenatide Injection recalled?
Amneal Pharmaceuticals of New York, LLC recalled Exenatide Injection in Aug 2026 — an FDA Class II recall (D-0868-2026) because Defective Delivery System: Possibility of no medication in the prefilled pen. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Exenatide Injection recalled?
Per the FDA enforcement record, the reason for recall D-0868-2026 was: Defective Delivery System: Possibility of no medication in the prefilled pen.
Is a recalled Exenatide Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Exenatide Injection are affected?
Distributed: USA Nationwide. The recall covers these lots — Lot #: AP250095A, Exp 2/28/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0868-2026.

Source: openFDA Drug Enforcement record D-0868-2026 ↗

← All drug recalls